BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 10772635)

  • 1. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.
    Fisher MB; Campanale K; Ackermann BL; VandenBranden M; Wrighton SA
    Drug Metab Dispos; 2000 May; 28(5):560-6. PubMed ID: 10772635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Aminobiphenyl N-glucuronidation by liver microsomes: optimization of the reaction conditions and characterization of the UDP-glucuronosyltransferase isoforms.
    Al-Zoughool M; Talaska G
    J Appl Toxicol; 2006; 26(6):524-32. PubMed ID: 17080401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.
    Mutlib AE; Goosen TC; Bauman JN; Williams JA; Kulkarni S; Kostrubsky S
    Chem Res Toxicol; 2006 May; 19(5):701-9. PubMed ID: 16696573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases.
    Yan Z; Caldwell GW; Gauthier D; Leo GC; Mei J; Ho CY; Jones WJ; Masucci JA; Tuman RW; Galemmo RA; Johnson DL
    Drug Metab Dispos; 2006 May; 34(5):748-55. PubMed ID: 16455802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
    Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
    Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; RamĂ­rez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4.
    Aprile S; Del Grosso E; Grosa G
    Drug Metab Dispos; 2010 Jul; 38(7):1141-6. PubMed ID: 20375181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucuronidation in the chimpanzee (Pan troglodytes): studies with acetaminophen, oestradiol and morphine.
    Wong H; Grace JE; Wright MR; Browning MR; Grossman SJ; Bai SA; Christ DD
    Xenobiotica; 2006 Dec; 36(12):1178-90. PubMed ID: 17162465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucuronidation of all-trans-retinoic acid and 5,6-epoxy-all-trans-retinoic acid. Activation of rat liver microsomal UDP-glucuronosyltransferase activity by alamethicin.
    Little JM; Lehman PA; Nowell S; Samokyszyn V; Radominska A
    Drug Metab Dispos; 1997 Jan; 25(1):5-11. PubMed ID: 9010623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
    Wen Z; Tallman MN; Ali SY; Smith PC
    Drug Metab Dispos; 2007 Mar; 35(3):371-80. PubMed ID: 17151191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes.
    Kaivosaari S; Toivonen P; Aitio O; Sipilä J; Koskinen M; Salonen JS; Finel M
    Drug Metab Dispos; 2008 Aug; 36(8):1529-37. PubMed ID: 18474681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucuronidation of anti-HIV drug candidate bevirimat: identification of human UDP-glucuronosyltransferases and species differences.
    Wen Z; Martin DE; Bullock P; Lee KH; Smith PC
    Drug Metab Dispos; 2007 Mar; 35(3):440-8. PubMed ID: 17151190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
    Gaganis P; Miners JO; Knights KM
    Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucuronidation of 1'-hydroxyestragole (1'-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9.
    Iyer LV; Ho MN; Shinn WM; Bradford WW; Tanga MJ; Nath SS; Green CE
    Toxicol Sci; 2003 May; 73(1):36-43. PubMed ID: 12657745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
    Hanioka N; Naito T; Narimatsu S
    Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxyl-glucuronidation of mitiglinide by human UDP-glucuronosyltransferases.
    Yu L; Lu S; Lin Y; Zeng S
    Biochem Pharmacol; 2007 Jun; 73(11):1842-51. PubMed ID: 17359941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway.
    Kerdpin O; Knights KM; Elliot DJ; Miners JO
    Biochem Pharmacol; 2008 Jul; 76(2):249-57. PubMed ID: 18541222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance.
    Kemp DC; Fan PW; Stevens JC
    Drug Metab Dispos; 2002 Jun; 30(6):694-700. PubMed ID: 12019197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.